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spatial cognition with hippocampal vulnerability
to apoptosis and deficits in synapses
Shao-hua Wang1*†, Yan Huang2†, Yang Yuan1, Wen-qing Xia1, Pin Wang1 and Rong Huang1Abstract
Background: Evidence from clinical studies support the fact that abnormal cholesterol metabolism in the brain
leads to progressive cognitive dysfunction. The low-density lipoprotein receptor (LDLR) is well-known for its role in
regulating cholesterol metabolism. Whether LDLR involved in this impaired cognition and the potential mechanisms
that underlie this impairment are unknown.
Methods: Twelve-month-old Ldlr−/− mice (n = 10) and wild-type littermates C57BL/6 J (n = 14) were subjected to
the Morris water maze test. At 1 week after completion of the behavioural testing, all of the animals were sacrificed
for analysis of synaptic and apoptotic markers.
Results: The plasma cholesterol concentration of Ldlr−/− mice was increased moderately when compared with
C57BL/6 J mice (P < 0.05). Behavioural testing revealed that Ldlr−/− mice displayed impaired spatial memory, and
moreover, the expression levels of synaptophysin and the number of synaptophysin-immunoreactive presynaptic
boutons in the hippocampal CA1 and dentate gyrus were decreased (all P < 0.05). Ultrastructural changes in the
dentate gyrus were observed using transmission electron microscopy. Furthermore, apoptosis in the hippocampus
of Ldlr−/− mice was revealed based on elevation, at both the mRNA and protein levels, of the ratio of Bax/Bcl-2
expression (all P < 0.05)and an increase in activated-caspase3 protein level (P < 0.05).
Conclusion: LDLR deficiency contributes to impaired spatial cognition. This most likely occurs via negative effects
that promote apoptosis and synaptic deficits in the hippocampus.
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Alzheimer’s disease (AD) is characterised by extracellular
amyloid plaques, intra-neuronal neurofibrillary tangles,
cerebrovascular amyloid deposits and a loss of neurons
and synapses in specific brain regions [1,2]. The mecha-
nisms are not fully understood. Accumulating evidence
from clinical [3-5], epidemiological [6-8], animal, cell cul-
ture [9] and genetic studies [2,8,10-12] suggests links be-
tween brain cholesterol and the development of AD.
Disturbed cerebral cholesterol metabolism is now gaining
attentions as a crucial aetiological factor underlying AD.
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unless otherwise stated.levels in plasma [13]. Cerebral cholesterol is highly enriched
and is synthesised de novo by glial cells, which also syn-
thesise apoE. The cholesterol is transported by apoE and
is taken up by neurons via specific receptors, primarily the
LDLR, for synaptogenesis and axonal growth [14].
In the periphery, the LDLR is well-known for its im-
portant role in removing cholesterol-rich lipoprotein
particles from the plasma to maintain cholesterol and
apoE homeostasis. In humans, LDLR deficiency causes
familial hypercholesterolaemia [15,16]. LDLR is widely
expressed in the brain [17-21] and as an important recep-
tor for apoE, LDLR plays a key role in brain cholesterol
metabolism and brain function. A cohort study has re-
vealed that LDLR-deficient patients showed a high inci-
dence of mild cognitive impairment [22]. Genetic studies
have revealed that LDLR is one of five cholesterol-relatedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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risk of developing AD [3,23]. In AD mouse models, LDLR
deficiency aggravates learning deficits and leads to in-
creased apoE levels and amyloid deposits [24,25]. More-
over, the overexpression of LDLR in the brain decreases
apoE levels and inhibits amyloid deposition markedly [26].
Furthermore, Ldlr−/− mice show modified transbilayer dis-
tribution of cholesterol in synaptic plasma membrane
preparations from the brain [27].
The hippocampus has frequently been used as a model
system of the brain and used widely for neurological
studies. The hippocampus is the key region underlying
learning and memory formation, and its normal function
depends upon the integrity of its neurons and synapses.
The LDLR is widely distributed in the hippocampus
[18]. LDLR plays a key role in cholesterol metabolism in
the brain. In regard to the hippocampus, we hypothe-
sised that an absence of LDLR may impair hippocampal
function and negatively impact cognitive function. In
this study, using Ldlr−/− mice, we imitated disordered
cholesterol metabolism in the brain and examined its in-
fluence on cognitive performance and the possible
underlying mechanisms. Our results will be helpful in
understanding the role of LDLR in cholesterol-related
cognitive impairment.
Experimental procedures
Animals and experimental design
A total of 24 four-month-old male LDLR deficient (Ldlr−/−)
mice (n = 10) and C57BL/6 J littermates (n = 14) were pur-
chased from the Model Animal Resource Information
Platform of Nanjing University. The Ldlr−/− mice (stock
#002207, strain name B6.12957-Ldlrtm1Her) were intro-
duced from the Jackson Laboratory (Bar Harbor, ME) in
2002 and were originally generated by homologous re-
combination in cultured embryonic stem cells to produce
mice that lack functional LDLR. The mice were then back-
crossed to C57BL/6 J mice for ten generations to obtain
homozygous Ldlr−/− mice on a C57BL/6 J background
[28]. The mice were housed under standard conditions in
conventional cages and had free access to food (standard
rodent chow diet, Xietong Organism, Jiangsu, China) and
water and were maintained at 21 ± 2°C on a 12 h light/
dark cycle (lights on at 7:00 a.m.). All of the experiments
were conducted in compliance with the National Institute
of Health Guidelines for the Care and Use of Laboratory
Animals (NIH Publications No.80-23), revised in 1996.
The Animal Care and Use Committee of the Southeast
University approved this animal study.
After one week of environmental adaptation, both the
Ldlr−/− and WT C57BL/6 J mice were subjected to a
Morris water maze test to determine their baseline cog-
nitive performance, and the test was performed again
8 months later when the mice were 12 months old. Thetesting was conducted and scored by experienced ob-
servers who were blind to the genetic background of the
mice. The body weight of each mouse was measured
monthly. At 1 week after the completion of the final be-
havioural test, the plasma lipids of mice were examined
as described previously [29]. The mice were anesthetised
using intraperitoneal sodium pentobarbital (80 mg/kg)
and killed. To perform the varied methods that are used
for the study of apoptotic and synaptic markers, the hip-
pocampal tissue was extracted immediately before or
after mice were perfused transcardially via a left ven-
tricular cannula with 4% phosphate-buffered paraformal-
dehyde (pH 7.4). At least three mice from each group
were used for each measurement.
Morris water maze test
To evaluate the spatial learning and memory of the mice,
Morris water maze testing was used as described previ-
ously [30,31]. The mice were tested between 8:00 am and
12:00 pm. The water maze pool (diameter, 122 cm;height,
50 cm) was filled to a depth of 30 cm using water (25 ± 2°C)
made opaque using milk powder. A black platform (8 cm
diameter, 1 cm below the surface of the water) was hidden
and was used by the mice as the escape from swimming.
The test included spatial acquisition and a probe test and
was performed over 5 days. For the spatial acquisition test,
during the first four days, the mice were trained with 3 tri-
als per day to locate the platform. The interval between
the 3 trials per day is 30 minutes. They were given a max-
imum of 60 sec to locate the hidden platform and were
permitted a stay of 10 sec on the platform. Those who
failed to locate the platform were guided to it by the ex-
perimenter and were also permitted a stay of 10 sec. For
analysis, the pool was subdivided into 4 equal quadrants
labelled N, S, E and W. The time required to reach the
platform (escape latency), the distance swam to the
platform, swimming speed and the percentage of time
spent swimming in the target quadrant were recorded
using a video tracking system (EthoVision Image Ana-
lysis 3.1, Noldus Information Technology, Wageningen,
The Netherlands). A probe test to assess the degree of
memory consolidation after learning was conducted on
the fifth day by removing the platform. Each mouse
was given a single 60 sec trial, and the time taken to
reach the original position of the platform and spent in
the target quadrant and the number of platform cross-
overs was recorded.
Electron microscopy
Damage to the DG region of the hippocampus often pre-
vents the growth of new born cells during the critical
period of memory formation, so ultrastructural changes in
the DG were observed using transmission electron mi-
croscopy. The DG tissue was extracted under a dissection
Table 1 The primers for real-time RT-PCR
Genes Primers
Bcl-2 5′- CTGGTGGACAACATCGCTCTG-3′ sense
5′- GGTCTGCTGACCTCACTTGTG-3′ antisense
Bax 5′- TCCAGGATCGAGCAGA-3′ sense
5′- AAGTAGAAGAGGGCAACC-3′ antisense
Caspase-3 5′- CATGGCCTGTCAGAAAATAC-3′ sense
Synaptophysin 5′- TAACCCGAGTAAGAATGTGC-3′ antisense
5′- CCCTACATTCACCCACTTCTCC-3′ sense
5′- TTATCTCCTCTCTGCCCGTTTC-3′ sense
GAPDH 5′- TGTTCCTACCCCCAATGTGTCCGTC-3′ sense
5′- CTGGTCCTCAGTGTAGCCCAAGATG-3′ antisense
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were generated that were fixed and subsequently treated
as described previously [32,33]. Morphological changes
in nerve cells and synapses were observed using an
AMTXR60 digital camera attached to a JEM 1400 trans-
mission electron microscope. We identified mitochondria
by the presence of distinctive cristae and a double mem-
brane and mature synapses by the presence of the follow-
ing features on at least one section: a postsynaptic
density, at least three synaptic vesicles within 100 nm of
the presynaptic membrane and a clearly defined synaptic
cleft.
Synaptophysin detection
With regard to synaptic density, we evaluated the num-
ber of presynaptic boutons using synaptophysin immu-
nostaining and the gene and protein expression levels of
synaptophysin. For synaptophysin immunostaining, the
hippocampus was cut into a series of 25-μm thick cor-
onal sections using a cryostat (Leica CM 3050; Leica,
Nussloch, Germany). For each animal, one subseries of 7
(every 10th) sections was used for free floating immuno-
fluorescence processing and synaptic density analyses.
The sections were incubated in PBS-T(0.3%Triton X-100
in PBS, pH7.4) for 1 h, then in blocking solution for 2 h,
and then with rabbit monoclonal anti-synaptophysin
(Abcam, 1:1000) overnight at 4°C. After washing, the sec-
tions were incubated for 2 h with FITC-conjugated goat
anti-rabbit IgG (Jackson, 1:100) and then incubated for
10 min with DAPI to stain the nuclei. To quantify the
density of synaptophysin-immunoreactive presynaptic
boutons (SIPBs), CA1 and DG regions within the hippo-
campus of both hemispheres were assessed in each sec-
tion. Three randomly chosen areas of the CA1 and DG
were examined by capturing confocal images using a
digital camera (F-view; Olympus, Tokyo, Japan) attached
to an Olympus AX-70 microscope (100× oil immersion
objective and a 10× projection lens). In total, 12 confocal
images per section and 84 images per animal were ob-
tained (3 images × 2 areas × 2 hemispheres × 7 sections).
For the quantification of the synaptophysin fluorescence
signal, images of labelled boutons were acquired using the
same settings. SIPBs were measured using Image-Pro Plus
software (Media-Cybernetics, Silver Spring, MD), as previ-
ously described [34,35]. Appropriate background correction
was first completed, and the immunoreactive presynaptic
boutons were then counted in sampling fields. The SIPB
density per unit area (100 μm2) was calculated. The data
from individual animals of each group were pooled.
Real-time RT-PCR
Real-time RT-PCR was used to investigate the mRNA
expression level of synaptophysin and the apoptosis-
related genes bcl-2, bax and caspase3 to analyse synapticdensity and neuronal apoptosis. Total RNA was ex-
tracted from the hippocampus using a trizol reagent kit
(Invitrogen). Total RNA (1 μg) was used as a template
for first-strand cDNA synthesis using random primers
and the Promega RT System. All of the PCR primers
were designed using the Primer Premier 5.0 software
(Table 1). The cDNA template (1 μL) was mixed into
the Master Mix (including 10 × SYBR Green PCR buffer,
25 mM MgCl2, 2.5 mM dNTP, 10,000× SYBR Green and
Taq DNA polymerase) together with 20 μM of each pri-
mer. The reaction mixture was brought up to a final vol-
ume of 25 μL with RNase-free deionised water. The
amplification conditions were 2 min at 30°C, 10 min at
95°C (Taq DNA polymerase activation), followed by
40 cycles of 20 s at 94°C (denaturing), 20 s at 55°C (an-
nealing) and 30 s at 72°C (extension). Real-time RT-PCR
was performed by monitoring the increase in fluores-
cence intensity of the SYBR Green dye using a Rotor-
Gene 3000 real-time PCR apparatus (Corbett Research)
according to the manufacturer’s instructions. All of the
measurements were performed in triplicate. The real-
time RT-PCR data are represented as Ct values, where
the Ct was defined as the threshold PCR cycle where the
amplified product was first detected. Tominimise intra-
and inter-assay variability caused by differences in PCR
efficiency, 5 replicates were performed. The Ct or thresh-
old value of the target sequence is directly proportional to
the absolute concentration when compared with the
threshold value of the reference genes. The relative ex-
pression levels of bcl-2, bax, caspase3 and synaptophysin
were plotted as the fold change compared with the control
and were determined using the 2-ΔΔCtmethod (21). This
method consists of analgorithm that calculates the relative
concentration. The factor X, which is the fold change in
the expression of the gene, can be calculated using the fol-
lowing formula: X = 2-ΔΔCt where ΔΔCt = (Ct of the target
gene – Ct of NAPDH) of the control group - (Ct of the
target gene - Ct of NAPDH) of the sample group.
Figure 1 Lipid analysis in C57BL/6 J and Ldlr−/− mice fed a
standard rodent chow diet. Total triglycerides (TGs), cholesterol
(TC), LDL-c and HDL-c levels in plasma samples collected from
12-h-fasted animals after completion of behavioural testing. *P <0.05
for Ldlr−/− vs. C57BL/6 J mice.
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The samples of hippocampal tissue were dissected on
ice and washed three times using cold PBS. They were
then homogenised in ice-cold lysis buffer (20 mM Tris,
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
TritonX-100, 2.5 mM Na-pyrophosphate, 1 mM β-
glycerophosphate, 1 mM Na3VO4, 1 g/mL leupeptin
and 1 mM PMSF). The samples were centrifuged at
14,000 rpm for 15 min. The protein concentration of the
supernatant was determined using a spectrophotometer
(Thermo). The loading buffer was added, and the sam-
ples were boiled for 3 min. Protein (50 μg) was then
loaded onto a 10% Bis-Tris gel (Invitrogen). The bands
were transferred to apolyvinylidene fluoride (PVDF)
membrane, which was then blocked using Tris-buffered
saline (TBS) containing 1% bovine serum albumin and
5% non-fat milk powder (w/v). The membrane was then
incubated overnight at 4°C with anti-bcl-2 (1:1000),
anti-bax (1:1000), anti-activated-caspase3 (1:1000) and
anti-synaptophysin (1:1000; all from Abcam) primary anti-
bodies. Immunoreactivity was detected using horseradish
peroxidase-conjugated secondary antibodies and visualised
using enhanced chemiluminescence. The expression levels
of each target protein and a GAPDH internal control were
quantified using densitometry (TotalLab, version 1.1, UK),
and the intensity of each target protein signal was normal-
ised to GAPDH. All of the data were expressed relative to
the control and represent the relative expression of each
target protein.
Statistical analyses
The data were analysed using SPSS16.0. The values are
represented as the means ± standard deviations (S.D.)
where indicated. A probability value of P < 0.05 was con-
sidered to be statistically significant. MWM spatial ac-
quisition and body weights were analysed using a
repeated measures analysis of variance (ANOVA) with
genotype (control and Ldlr−/−) as the between-subjects
factor and time (days 1–4 and months 1–8) as the
within-subjects factor, respectively. Bonferroni-corrected
t-tests were further used to examine significant differ-
ences between experimental time points or between ani-
mal groups. The MWM probe test, serum cholesterol,
immunofluorescence staining, real time RT-PCR, west-
ern blotting and electron microscopy data were analysed
using t-tests.
Results and discussion
Body weight gain and lipid analyses
The Ldlr−/− mice appeared healthy, and no differences in
physical appearance or behaviour in the home cage was
apparent between the groups. Repeated measures ana-
lysis of variance showed that the body weight of both
groups increased steadily (F(8,196) = 197.83, P < 0.001)over the 8-month period. There was no statistically sig-
nificant effect of Ldlr deficiency on body weight gain
(F(1,22) = 0.15, P = 0.71). The weight of the C57BL/6 J
and Ldlr−/− mice was 42 ± 4 g and 42 ± 2 g by 12 months
of age. With regard to plasma lipids, we determined the
levels of plasma cholesterol, triglyceride, HDL-c and
LDL-c. Total (fasting) plasma cholesterol (TC) values
were approximately three-fold higher in the Ldlr−/− mice
compared with theC57BL/6 J mice (t(4) = 4.08, P = 0.02)
due to an eight-fold increase in LDL-c (t(4) = 3.77, P = 0.02),
whereas there was no significant change in HDL-c
(t(4) = 2.31, P = 0.14). There was no significant difference
in plasma levels of triglycerides between the two groups
(t(4) = 2.13, P = 0.10) (Figure 1).
Morris water maze test
During the baseline MWM test, the escape latencies
(F(3,66) = 10.20, P < 0.001), distances (F(3,66) = 15.16,
P < 0.001) and swim speeds (F(3,66) = 11.52, P < 0.001)
decreased in both groups over the 4-day spatial acquisition
test period indicating that all of the mice learned the task
quickly. However, neither these three above-mentioned in-
dices nor the target quadrant time percentage differed be-
tween the groups. For the probe trial test, no differences
in the time taken to reach or to stay in the target square,
the distance swam and the swim speed or platform cross-
overs were found between the two groups. These results
indicated that Ldlr−/− mice did not show impaired spatial
cognition at baseline.
Eight months later, the MWM test indicated that during
the spatial acquisition test period, the escape latencies
(Figure 2A) and distances swam (Figure 2B) to reach the
hidden platform were similarly decreased in both groups
over the four testing days (F(3, 66) = 8.68, P < 0.01). No
Figure 2 The spatial acquisition phase of the MWM task. The data shown are escape latencies (A), distances moved (B), swim speed (C), the
percentage of time spent in the target quadrant (D) and representative swim paths (E) during the spatial acquisition test (three trials per day
over four successive days) of the MWM task in C57BL/6 J (n = 14) and Ldlr−/− mice (n = 10) groups. **P < 0.01 for Ldlr−/− vs. C57BL/6 J mice.
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the two groups (Figure 2C). Repeated measures analysis
of variance (ANOVA) showed significant effects of Ldlr
deficiency on the reduced percentage of time spent swim-
ming in the target quadrant (F(3,66) = 10.90, P = 0.01)
(Figure 2D), showing a poorer learning performance. Sub-
sequent Bonferroni post-hoc tests confirmed that the
percentage time was significantly less on day 3 (t = 2.74,
P = 0.02) and day 4 (t = 2.79, P = 0.03) in Ldlr−/− mice.
Typical swimming patterns observed on day 4 of the
training period suggested that C57BL/6 J mice found the
platform primarily by tendency and linear patterns,whereas the Ldlr−/− mice swam at the margins, and the
swimming patterns were random (Figure 2E). For the
probe trial, the platform was removed, and the Ldlr−/−
group failed to remember the precise location of the
platform and spent significantly less time in the target
quadrant (t = 4.52, P = 0.001; Figure 3A). No statistically
significant differences were noted between the two
groups in the time spent reaching the target square,the
distance swam or swim speed or in platform crossovers.
Typical swimming patterns (Figure 3B) during the probe
test showed that the C57BL/6 J mice looked for the plat-
form by shuttling back and forth. In contrast to the
Figure 3 The probe test of the MWM task. The data shown are the time spent in the target quadrant (A) and representative swim paths
(B) during the probe test (performed on the fifth day after the first four days of training). *P < 0.05 for Ldlr−/− vs. C57BL/6 J mice.
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to search for the platform using patterns at the margin.
Electron microscopy
Ultrastructural analysis of the dentate gyrus revealed ro-
bust differences between Ldlr−/− and C57BL/6 J mice.
In Ldlr−/− mice, lipid particles were widely distributed
in the cytoplasm of glial cells indicating increased intra-
cellular lipid deposition (the “→” label in Figure 4Ae).
The ultrastructural arrangement was loose and showed
oedema (the “#” label in Figure 4Af). The morphology of
the neurofibrils was sparse, and their arrangement was
disordered (the “□” label in Figure 4Ag) which is ampli-
fied in (Figure 4Ah). Analyses of synapses showed wider
synaptic clefts between the two synaptic membranes and
decreased synaptic vesicles (the “*” label in Figure 4Af).
In tissue from C57BL/6 J mice, the mitochondria, neurofi-
brils and synapses showed no evidence of lipid deposition
(Figure 4Aa). Neatly arranged mitochondrial cristae and
neurofibrils as well as normal synaptic clefts and synaptic
vesicles were also observed (Figure 4Ab-c).
Synaptophysin detection
Synaptic density was measured in the hippocampal CA1
and DG regions using synaptophysin immunoreactivity.
Representative images of synaptophysin-stainedpresynaptic boutons are shown in Figure 4Ba-b. As
shown in Figure 4Bc, the SIPBs in the hippocampal CA1
and DG regions were lower in Ldlr−/− mice than in
C57BL/6 J mice (t = 3.50, P = 0.001; t = 6.38, P < 0.001,
respectively).
The mean protein (Figure 5A) and mRNA (Figure 5B)
expression levels of synaptophysin in the Ldlr−/− mice,
which showed cognitive decline, were lower than in the
C57BL/6 J mice (t = −6.05, P = 0.004; t = −6.53, P = 0.003,
respectively).
Apoptosis and apoptosis-related genes
The mean ratio of Bax/Bcl-2 protein (Figure 6A) and
mRNA (Figure 6B) was approximately 5-6-fold higher in
Ldlr−/− mice compared with C57BL/6 J mice (t = 6.16,
P = 0.004; t = 4.37, P = 0.01, respectively). Individually,
the mean levels of Bax protein and mRNA in Ldlr−/−
mice with cognitive decline were higher than in C57BL/6 J
mice (t = 9.79, P = 0.009; t = 4.68, P = 0.009, respectively)
whereas the mean levels of Bcl-2 were lower in Ldlr−/− mice
than in C57BL/6 J mice (t = −7.03, P = 0.002; t = −8.67,
P = 0.001, respectively). Moreover, there was no significant
difference in caspase-3 mRNA expression (Figure 6D) be-
tween the two groups, but activated-caspase3 protein level
(Figure 6C) was higher in the Ldlr−/− mice compared with
C57BL/6 J mice (t = 3.07, P = 0.04).
Figure 4 Pathological changes in the hippocampus. A: Electron microscopic examination of the DG stratum radiatum. The data of C57BL/6 J
mice shown in a-d are ultrastructural analyses of DG general tissue (a), mitochondrial and synapse ultrastructure (“*” in b), neurofibrils (“□”in c)
which is amplified in (d). the data of Ldlr−/− mice shown in e-h are glial cell lipid deposition (“→”in e), ultrastructural loose arrangement and
oedema (“#”in f), a decrease in synaptic vesicles (“*” in f) , and sparse neurofibrils (“□”in g) which is amplified in (h). Scale bar = 2 μm in a and e;
0.2 μm in b, c, f and g; 0.04 μm in d and h. B: Density of synaptophysin-immunoreactive presynaptic boutons (SIPBs) in the hippocampus of Ldlr−/−
mice. A representative image of the hippocampus of a C57BL/6 J mouse (a) and Ldlr−/− mouse (b) at 20 ×magnification is shown. Quantitative data
showing a significant decrease in SIPBs in both the CA1 and DG subregions in Ldlr−/− mice (C). Scale bar = 25 μm in a and b. **P < 0.01 for Ldlr−/− vs.
C57BL/6 J mice.
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Figure 5 Effects of LDLR knockout on synaptophysin expression
in the hippocampus of C57BL/6 J and Ldlr−/− mice. The data
shown are of mRNA (B) and protein (A) levels of synaptophysin in the
hippocampus. **P < 0.01 for Ldlr−/− vs. C57BL/6 J mice.
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The LDLR is well known for its role in peripheral chol-
esterol homeostasis [36]; however, it has only been
within the last decade has the investigation of choles-
terol metabolism in the brain gained momentum [37].
This increased interest is most likely because cerebral
cholesterol is implicated in neurodegenerative disease.
Here, we used Ldlr−/− mice to imitate the deregulation
of cerebral cholesterol. The most striking findings of this
study are that Ldlr−/− mice show impaired spatial cogni-
tion together with increased intracellular lipid depos-
ition, decreased synapse density and increased neuronal
apoptosis in the hippocampus.
Consistent with previous studies [28,38], our data
showed that plasma TC and LDL-c levels in 12-month-
old Ldlr−/− mice increased two- and seven-fold, respect-
ively, when fed a standard laboratory chow diet. Unlike
humans, LDLR deficiency in mice did not increase
plasma lipids significantly. However, ultrastructural stud-
ies revealed a rich deposition of intracellular lipid in
glial cells, providing direct evidence of the disordered
cholesterol metabolism in brains of Ldlr−/− mice. ApoEis generated exclusively by glial cells, and these cells are
most likely the source of the cholesterol-apoE particles.
The deposition of lipid particles results from a decrease
in cholesterol-apoE particle uptake by neurons. Thus,
we infer that LDLR deficiency in mice affects choles-
terol metabolism in brain rather than the peripheral
circulation.
Absence of Ldlr might have (or most likely) contrib-
uted to impaired spatial cognition, which was observed
previously using the MWM test in 6-month-old mice
[39]. They display a decreased number of synaptophysin-
immunoreactive presynaptic boutons (SIBPs) in the hippo-
campus CA1. The MWM test has been proven correlate
with hippocampal synaptic plasticity [40]. Our behavioural
data were supported by the observation that Ldlr−/− mice
displayed a decrease in synapse density/number, as shown
by the reduced SIBPs in hippocampal DG other than CA1
regions and the decreased expression of synaptophysin.
Ultrastructural examination of Ldlr−/− mice revealed mul-
tiple synaptic changes, including decreased vesicles and
widened clefts in the DG. A decrease in synapses is one of
the characteristics of neurodegenerative diseases [41].
Whether it occurs before the death of neurons remains in-
conclusive; however, it certainly correlates with neuronal
degeneration and death. The hippocampal DG region is
one of few brain structures currently known to have high
rates of neurogenesis in adult rats [42], contributing to the
formation of new episodic memories [43], the spontan-
eous exploration of novel environments, and other func-
tions [44]. Neurons created in the DG must be established
synaptically into the circuitry before they are mature [45].
Synapses contain large membranes in postsynaptic spines
and in presynaptic vesicles, which have a particularly high
content of cholesterol [46]. A continuous supply of choles-
terol is required for synaptogenesis, the results may be ex-
plained by the possibility that reduced cellular uptake of
cholesterol in Ldlr−/− mice underlies the reduction in syn-
aptic plasticity. In contrast, although the mean cerebral
total cholesterol content in Ldlr−/− mice did not differ
from that of C57BL/6 J mice [25], research has shown that
cholesterol distribution in the plasma membrane is un-
even and that the LDLR plays a role in modulating the
transbilayer or asymmetric distribution of cholesterol in
the exofacial and cytofacial leaflets of the synaptic plasma
membranes. Ldlr−/− mice have been shown to display an
increase in the percentage distribution of cholesterol and
decreased fluidity in the exofacial leaflet [27], which may
affect synaptic transmission. Changes intransbilayer or
asymmetric distribution of cholesterol may increase Aβ
deposition in the brain [47,48] and enhance synaptic exci-
totoxicity [49,50].
The most important feature of AD pathology is neuro-
degeneration. It has been well documented that some
pathological neuronal loss in AD occurs via apoptosis.
Figure 6 Effects of LDLR knockout on expression of the apoptosis-related genes Bax, Bcl-2 and caspase3 in the hippocampus of
C57BL/6 J and Ldlr−/− mice. The data shown are the ratio of protein (A) and mRNA (B) levels of Bax to Bcl-2, the levels of activated-caspase3
protein (C) and caspase-3 mRNA (D) are also quantified in the hippocampus. *P < 0.05, **P < 0.01 for Ldlr−/− vs. C57BL/6 J mice.
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http://www.lipidworld.com/content/13/1/175In the present study, the pro-apoptotic gene bax was
expressed at higher levels, and expression of the anti-
apoptotic gene bcl-2 was lower at both the mRNA and
protein levels in the hippocampus of Ldlr−/− mice. These
results indicate that Ldlr−/−-mediated distribution of
brain cholesterol metabolism led to an increase in apop-
tosis. Ldlr−/−-mediated reduced cellular uptake of chol-
esterol may promote neuronal death. A deterioration
intransbilayer or asymmetric distribution of choles-
terol contributes to Aβ deposition, and Aβ oligomers
have been shown to induce neuronal apoptosis via
the SM-ceramide pathway [51]. In hippocampal DG,
Ldlr−/− -induced apoptotic injury potentially suppress
the formation of new neurons, and their integration
into the neuronal circuitry of the hippocampal net-
work was further hindered through weakening synap-
tic connections.
Certain limitations existed when we interpreted the
data presented in this study. Cholesterol metabolism in
mice differs substantially from that in humans. Although
it is unknown whether differences in lipoprotein metab-
olism in the brain exist between mice and humans, a re-
cent cohort study revealed that Ldlr−/− patients showeda six-fold higher incidence of mild cognitive impairment
compared with those without Ldlr mutations [22], indi-
cating that LDLR may play similar roles in brain choles-
terol metabolism and in maintaining brain function in
both humans and mice. Although some ultra-structural
changes were observed using transmission electron mi-
croscopy, these changes could not be the direct evidence
that indicating deterioration in cholesterol homeostasis
in the brain. We cannot explain the exact mechanisms
that link apoptosis and synapses deficit to the possible
brain cholesterol dyshomeostasis. We also should have
studied the levels of various neurotransmitters in various
areas of the brain, to show that the impaired spatial cog-
nition is only due to synaptophysin but not due to
changes in neurotransmitters. But the neurotransmitters
in the brain are very complex, the changes of synapto-
physin itself may be caused by other neurotransmitters,
and vice versa [52-54]. So that it is very difficult to elim-
inate the effects of these confounding factors. Addition-
ally, the number of animals used for the cellular and
molecular biology assays is low. Apoptotic markers like
Annexin V or others may be used to quantify the amount
of apoptosis.
Wang et al. Lipids in Health and Disease 2014, 13:175 Page 10 of 11
http://www.lipidworld.com/content/13/1/175This study has demonstrated the adverse effects of
cholesterol deregulation in the brain on spatial cognition
in the Ldlr−/− mouse model. Our findings indicate that
LDLR deficiency results in impaired spatial cognition
most likely via its deteriorating effect on homeostasis of
cerebral cholesterol and negative effects on hippocampal
vulnerability to apoptosis and number of synapses.
These results will be helpful in understanding the role of
LDLR in cholesterol-related cognitive impairment.
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